Pulmonary Fibrosis Clinical Trials: Exploring Research and Insights into Participation - Centre of Research Excellence in Pulmonary Fibrosis

The Centre of Research Excellence in Pulmonary Fibrosis produced this webinar in partnership with Lung Foundation Australia.

Join expert speakers, A/Prof Vidya Navaratnam and Prof Ian Glaspole, as they provide an overview of clinical trials for pulmonary fibrosis (PF) including how trials work, recent research breakthroughs, and what’s involved in participation.

The webinar explores how clinical trials are conducted in stages. Phase 1 trials assess whether a new drug is safe. Phase 2 trials explore whether it works in people with the disease. Phase 3 trials involve larger groups to compare new treatments with standard care. Many studies also include an open-label extension, where all participants receive the study drug to assess long-term benefits and safety.

Several promising treatments are highlighted in the webinar.

Pulmonary Fibrosis Institute

The Centre of Research Excellence in Pulmonary Fibrosis has established the Pulmonary Fibrosis Institute, a not-for-profit company registered in Australia. The Pulmonary Fibrosis Institute exists to support ongoing research into pulmonary fibrosis and ensure the longevity of research infrastructure developed through our collaborative efforts.